Clear Harbor Asset Management’s SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-3,075
| Closed | -$277K | – | 426 |
|
|
2024
Q4 | $277K | Hold |
3,075
| – | – | 0.02% | 310 |
|
|
2024
Q3 | $304K | Buy |
3,075
+60
| +2% | +$5.93K | 0.02% | 288 |
|
|
2024
Q2 | $280K | Hold |
3,015
| – | – | 0.02% | 291 |
|
|
2024
Q1 | $286K | Sell |
3,015
-197
| -6% | -$18.7K | 0.03% | 292 |
|
|
2023
Q4 | $287K | Sell |
3,212
-1,135
| -26% | -$101K | 0.03% | 269 |
|
|
2023
Q3 | $317K | Buy |
4,347
+134
| +3% | +$9.79K | 0.03% | 253 |
|
|
2023
Q2 | $351K | Buy |
4,213
+975
| +30% | +$81.1K | 0.03% | 255 |
|
|
2023
Q1 | $247K | Sell |
3,238
-25
| -0.8% | -$1.91K | 0.03% | 311 |
|
|
2022
Q4 | $271K | Sell |
3,263
-1,100
| -25% | -$91.3K | 0.03% | 271 |
|
|
2022
Q3 | $346K | Sell |
4,363
-1,127
| -21% | -$89.4K | 0.05% | 243 |
|
|
2022
Q2 | $408K | Buy |
+5,490
| New | +$408K | 0.05% | 232 |
|
|
2022
Q1 | – | Hold |
0
| – | – | – | 436 |
|
|
2021
Q4 | – | Hold |
0
| – | – | – | 425 |
|
|
2020
Q4 | – | Sell |
-110
| Closed | -$12.3K | – | 727 |
|
|
2020
Q3 | $12.3K | Buy |
+110
| New | +$12.3K | ﹤0.01% | 555 |
|